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                                                             ABSTRACT 32 
After nerve injury, myelin and Remak Schwann cells reprogram to repair cells specialized for 33 
regeneration. Normally providing strong regenerative support, these cells fail in aging 34 
animals, and during chronic denervation that results from slow axon growth. This impairs 35 
axonal regeneration and causes significant clinical problems. In mice, we find that repair 36 
cells express reduced c-Jun protein as regenerative support provided by these cells declines 37 
during aging and chronic denervation. In both cases, genetically restoring Schwann cell c-38 
Jun levels restores regeneration to control levels. We identify potential gene candidates 39 
mediating this effect and implicate Shh in the control of Schwann cell c-Jun levels. This 40 
establishes that a common mechanism, reduced c-Jun in Schwann cells, regulates success 41 
and failure of nerve repair both during aging and chronic denervation. This provides a 42 
molecular framework for addressing important clinical problems, suggesting molecular 43 
pathways that can be targeted to promote repair in the PNS. 44 
 45 
 46 













                                                         INTRODUCTION 58 
 Among mammalian systems, peripheral nerve is often hailed as a prime example of a tissue 59 
with a striking regenerative potential. Nerve injury triggers the reprograming of myelin and 60 
non-myelin (Remak) Schwann cells to adopt a repair Schwann cell phenotype specialized to 61 
support regeneration, and injured neurons activate a gene program that facilitates axon 62 
growth. Yet, paradoxically, the clinical outcome of nerve injuries remains poor, and nerve 63 
damage constitutes a significant clinical and economic burden. Remarkably, treatment of 64 
nerve injuries has not advanced significantly for decades (Furey et al. 2007; Jonsson et al. 65 
2013; reviewed in Fu and Gordon 1995; Boyd and Gordon 2003a; Hoke 2006; Allodi et al. 66 
2012; Scheib and Hoke 2013; Doron-Mandel et al. 2015; Jessen and Mirsky 2016; Fawcett 67 
and Verhaagen 2018; Jessen and Arthur-Farraj 2019).   68 
The question of why a potentially regenerative tissue fails to respond effectively to injury and 69 
ensure clinical recovery is important both for promoting nerve repair, and also more 70 
generally. A number of other systems with experimentally established regenerative capacity, 71 
e.g. skin, heart and pancreatic islets, also fail to show clinically useful regenerative response 72 
to tissue damage (Cohen and Melton, 2011; Eguizabal et al. 2013; Jessen et al. 2015). 73 
 In the case of peripheral nerves, recent work has highlighted two important factors that 74 
prevent full expression of their regenerative potential. One is the age of the animal at the 75 
time of injury, increasing age resulting in a marked decrease in regeneration. The other is 76 
the adverse effect of chronic denervation on the nerve distal to injury, since this tissue 77 
gradually loses the capacity to support axon growth as it lies denervated during the often 78 
extensive time it takes regenerating axons to reach their targets. These two problems turn 79 
out to involve a common factor, namely a repair Schwann cell failure, since both during 80 
aging and chronic denervation, the denervated Schwann cells in the distal stump undergo 81 
molecular and morphological changes that result in a striking functional deterioration of 82 
these important drivers of axonal regeneration (reviewed in Verdu et al 2000; Sulaiman and 83 
Gordon 2009; Painter 2017; Jessen and Mirsky 2019). 84 
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In the present work, we have tested whether the dysfunction of repair Schwann cells in these 85 
two apparently unrelated situations relates to a common factor, namely a failure to activate 86 
or maintain high levels of the transcription factor c-Jun. That this might be so, is based on 87 
our previous finding that c-Jun, which is upregulated in Schwann cells in injured nerves, is a 88 
global amplifier of the repair Schwann cell phenotype (Arthur-Farraj et al. 2012; reviewed in 89 
Jessen and Mirsky 2016; 2019; Jessen and Arthur-Farraj 2019), and on subsequent findings 90 
showing that enhanced Schwann cell c-Jun promotes regeneration, both through nerve 91 
grafts and in vitro (Arthur-Farraj et al. 2012; Huang et al. 2015; 2019). 92 
 The age-dependent decline in regenerative capacity of human and animal nerves is well 93 
established (Pestronk et al. 1980; Tanaka and Webster 1991; Tanaka et al. 1992; 94 
Graciarena et al. 2014; reviewed in Vaughan 1992; Verdú et al. 2000; Ruijs et al. 2005). This 95 
is associated with a reduced initial inflammatory response followed by enhanced chronic 96 
inflammation (Scheib and Höke 2016; Büttner et al. 2018). Interestingly, diminished 97 
regeneration is not caused by age-dependent changes in neurons. Rather, aging results in 98 
subdued activation of the repair Schwann cell phenotype after injury, including reduced c-99 
Jun expression, resulting in regeneration failure (Painter et al. 2014; reviewed in Painter 100 
2017).  101 
The other major barrier to repair that we consider here is caused by long-term denervation of 102 
nerves distal to injury. This is an important issue in human nerve regeneration (Ruiis et al. 103 
2005), and has been studied in some detail in rats, revealing that chronic denervation results 104 
in reduced expression of repair-associated genes including Gdnf, Bdnf, Ntf3 and Ngfr, 105 
accompanied by a dramatic reduction in the ability of denervated distal stumps to support 106 
regeneration even of freshly transected axons (Fu and Gordon 1995; You et al. 1997; 107 
Sulaiman and Gordon 2000; Höke et al. 2002; Michalski et al. 2008; Eggers et al. 2010). 108 
There is direct evidence for a comparable deterioration of repair cells and repair capacity 109 
during chronic denervation of human nerves (Wilcox et al. 2020; reviewed in Ruijs et al. 110 
2005). Chronic denervation also results in reduced repair cell numbers and shortening of 111 
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repair cells (Benito et al. 2017; Gomez-Sanchez et al. 2017; reviewed in Jessen and Mirsky 112 
2019). Thus, the repair phenotype is not stable, but fades with time after injury, thereby 113 
contributing to the poor outcome after nerve damage in humans. 114 
Schwann cell reprograming after nerve injury involves up-regulation of trophic factors and 115 
cytokines, activation of EMT genes, and myelin autophagy for myelin clearance and down-116 
regulation of myelin genes (Brushart et al. 2013; Arthur-Farraj et al. 2017; Clements et al. 117 
2017; reviewed in Gröthe et al. 2006; Chen et al 2007;  Gambarotta et al. 2013; Glenn and 118 
Talbot 2013; Jessen and Mirsky 2016; Boerboom et al. 2017; Jessen and Arthur-Farraj 119 
2019; Nocera and Jacob 2020). Myelin and Remak Schwann cells also increase in length by 120 
two-to-three fold and often branch as they convert to repair cells and form regeneration 121 
tracks, Bungner bands, that guide regenerating axons (Gomez-Sanchez et al. 2017). The 122 
molecular signals involved in the decline of these repair-supportive features during aging 123 
and chronic denervation have not been known. 124 
The transcription factor c-Jun regulates the reprograming of myelin and Remak cells to 125 
repair cells by accelerating the extinction of myelin genes, promoting myelin breakdown, and 126 
by amplifying the up-regulation of a broad spectrum of repair-supportive features, including 127 
the expression of trophic factors. Accordingly, genetic removal of c-Jun from Schwann cells 128 
results in functionally impaired repair cells and regeneration failure (Arthur-Farraj et al. 2012; 129 
Fontana et al., 2012; reviewed in Jessen and Arthur-Farraj 2019). 130 
Here we provide evidence that a common molecular mechanism, the dysregulation of c-Jun 131 
in Schwann cells, is central to two major categories of regeneration failure in the PNS.  The 132 
high levels of Schwann cell c-Jun triggered by nerve injury in young animals are not 133 
achieved in older ones, and, irrespective of age, the elevated c-Jun expression seen after 134 
injury steadily decreases during long-term denervation. Importantly we show that in both 135 
models of regeneration failure, genetically restoring Schwann cell c-Jun levels in vivo also 136 
restores regeneration rates to that in controls. By establishing c-Jun as an important 137 
regulator of the success and failure of nerve repair during aging and chronic denervation this 138 
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observation provides a common molecular framework for addressing an important clinical 139 
problem, and suggests molecular pathways that can be targeted to promote repair in the 140 
PNS 141 
 142 
                                                            RESULTS 143 
IN AGING ANIMALS, MAINTAINING C-JUN LEVELS IN SCHWANN CELLS REVERSES 144 
AGE-RELATED DEFECTS IN NERVE REGENERATION 145 
Age-dependent failure of nerve regeneration is accompanied by subdued elevation of c-Jun, 146 
a major regulator of the repair cell phenotype (Painter et al. 2014). To test whether this 147 
reduction in c-Jun controls the reduced capacity of these cells to support axon growth, we 148 
first compared c-Jun upregulation in young and older WT mice (Fig.1 A). Four days after 149 
transection, c-Jun protein levels in the distal nerve stump in aged mice (8-10 month) were 150 
found to be ~ 50% lower than in young (6-8 week) mice.  151 
To determine the functional significance of this, we studied MpzCre+;R26c-Junstopff/+ mice 152 
(referred to as c-Jun OE/+ mice), which we generated previously (Fazal et al. 2017). In these 153 
mice, c-Jun levels are enhanced in Schwann cells only. In Western blots of uninjured adult 154 
sciatic ;nerves of c-Jun OE/+ mice, c-Jun is elevated about seven fold compared to WT. 155 
While there is a modest reduction in myelin thickness, nerve architecture and Schwann cell 156 
morphology are normal (Fazal et al. 2017). We found that in c-Jun OE/+ mice, the age-157 
dependent decline in c-Jun protein levels after sciatic nerve cut was prevented, and that c-158 
Jun levels in the distal stump of young WT and aging c-Jun OE/+ mice were similar by 159 
Western blots 4 days after cut (Fig.1 A). At the mRNA level, a non-significant trend towards 160 
lower c-Jun expression was seen in 3 day cut nerves of aged WT nerves, while there was a 161 
significant elevation of c-Jun mRNA in cut c-Jun OE/+ nerves as expected (Fig.1 B).  162 
c-Jun levels seen in Western blots were confirmed in immunofluorescence experiments on 3 163 
day cut nerves, using Sox10 antibodies to selectively identify Schwann cell nuclei, and c-Jun 164 
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antibodies (Fig.1C).  In WT mice, older nerves contained fewer c-Jun positive Schwann cell 165 
nuclei and the labeling of the c-Jun positive nuclei was weaker, compared to young nerves. 166 
In aged c-Jun OE/+ nerves nuclear c-Jun was restored to levels similar to those in young 167 
WT nerves.  168 
Regeneration in young and aged WT mice and aged c-Jun OE/+ mice was compared using 169 
neuron back-filling, a method that provides an optimal measure of regenerative capacity by 170 
determining the number of neuronal cell bodies have regenerated axons through a nerve at 171 
a measured distance distal to injury (Fig. 1 Figure Supplement 1)  (Novikova et al.1997; 172 
Boyd and Gordon 2003b; Catapano et al. 2016). Four days after sciatic nerve crush, 173 
retrograde tracer was applied to the distal stump 7 mm from the crush site. Seven days later, 174 
the animals were sacrificed and the number of back-filled DRG and spinal cord motor 175 
neurons were counted. The results were comparable for both neuronal populations (Fig.1 D, 176 
E). The number of neurons regenerating through the distal stump of aged WT mice was 177 
reduced by about 50% compared to young mice. In aged c-Jun OE/+ mice on the other 178 
hand, regeneration of DRG and motor neurons was restored to levels similar to those in 179 
young WT nerves.  180 
In confirmation, counts of CGRP+ fibers in the sciatic nerve were performed 3 days after 181 
nerve crush, 3mm from the injury site (Fig.1 F). The number of fibers were reduced in aged 182 
WT nerves compared to young ones, but increased in the aged c-Jun OE/+ nerves.  183 
These experiments confirm that the failure of repair cell function in older animals is 184 
accompanied by failure to fully upregulate c-Jun in Schwann cells after injury (Painter et al. 185 
2014). Importantly, restoration of c-Jun elevation selectively in Schwann cells to that seen in 186 
young animals is sufficient to restore nerve regeneration to youthful levels. 187 
 188 
A MOUSE MODEL OF DISTAL STUMP DETERIORATION 189 
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We established a model of chronic denervation in mice, since previous studies have been 190 
carried out in rats. Sciatic nerves were cut followed by deflection of the proximal stump to 191 
leave the distal stump un-innervated for 1 week (short-term denervation) or 10 weeks 192 
(chronic denervation). mRNA levels for genes associated with denervated Schwann cells 193 
(S100b, Ngfr, Gdnf, and sonic hedgehog (Shh)) declined substantially between 1 and 10 194 
weeks of denervation (Fig.2 A). Western blots of p75NTR (Ngfr) in the distal stump showed 195 
a rise to a maximum 1 week after injury and a decline thereafter to < 50% of peak levels at 196 
10 weeks (Fig. 2 B) in line with that seen in rat (You et al. 1997). 197 
 Regeneration through freshly cut and long-term denervated nerve stumps were compared 198 
by back-filling of spinal cord motor neurons. For this, acutely cut (immediate repair) or 10 199 
week denervated tibial distal stumps were sutured to freshly cut peroneal nerves (Fig.2 200 
Figure Supplement 1 Two weeks later, Fluorogold retrograde tracer was applied to the tibial 201 
stumps 4mm distal to the suturing site. One week after the application of tracer, the number 202 
of retrogradely labeled motor neurons in the spinal cord was counted. Only about half as 203 
many spinal cord motor neurons projected into the 10 week denervated stumps compared to 204 
the acutely transected stumps (Fig.2 C).  205 
Failure of regeneration through 10 week denervated stumps was confirmed by 206 
immunohistochemistry and counting of neurofilament positive axons in similar experiments. 207 
Ten week denervated stumps contained many fewer regenerating neurofilament labeled 208 
axons than nerve stumps sutured immediately after transection (Fig.2 D).  209 
Counting back-filled neurons following immediate repair or repair 1 week after transection, 210 
revealed a similar number of regenerating neurons (Fig.2 E). This shows that the capacity of 211 
the distal stump to support regeneration declines between 1 and 10 weeks of denervation.  212 
 These experiments established a baseline for studying the effects of prolonged denervation 213 




c-JUN IS DOWN-REGULATED IN CHRONICALLY DENERVATED SCHWANN CELLS 216 
We determined whether decline in Schwann cell c-Jun expression was involved in 217 
regeneration failure caused by chronic denervation, as seen during aging. Measuring c-Jun 218 
protein levels in distal stumps showed strong elevation 3 days and 1 week after sciatic nerve 219 
cut followed by a decline to ~40% of 1 week levels at 10 weeks (Fig.3 A). We verified that 220 
the c-Jun shown in these Western blots represented c-Jun in Schwann cells, using mice with 221 
conditional c-Jun inactivation selectively in Schwann cells (Arthur-Farraj et al. 2012) (Fig.3 222 
B). Further, 1 and 10 week denervated stumps were compared using double 223 
immunofluorescent labeling with c-Jun antibodies and Sox10 antibodies to selectively 224 
identify Schwann cell nuclei. Ten week denervated stumps showed many more c-Jun 225 
negative, Sox10 positive nuclei, and the c-Jun labeling, where present, was also weaker 226 
(Fig.3 C).  227 
The decline in c-Jun and p75NTR expression after long-term denervation in vivo was 228 
mimicked in purified Schwann cells in vitro. By Western blots, cells that had been maintained 229 
~6 weeks in vitro (9 passages), contained less c-Jun and p75NTR protein compared to cells 230 
maintained ~10 days in vitro (2 passages) (Fig.3 D). The levels of c-Jun mRNA also declined 231 
in long-term cultures (Fig.3 E) The reduction in c-Jun in Schwann cell nuclei was confirmed 232 
using double immunofluorescent labeling with c-Jun and Sox 10 antibodies to identify 233 
Schwann cells (Fig.3 F). These in vitro experiments suggests that the decline in c-Jun and 234 
p75NTR during chronic denervation is not driven by endoneurial signals. 235 
 236 
C-JUN DOWN-REGULATION DURING CHRONIC DENERVATION IS PREVENTED IN C-237 
JUN OE/+ MICE 238 
The decline in c-Jun levels at the same time as repair cells lose capacity to support 239 
regeneration raises the questions of whether the functional deterioration of these cells is 240 
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partly a consequence of c-Jun reduction, and whether repair cells, and regeneration through 241 
chronically denervated nerves, would be maintained if c-Jun reduction was prevented. 242 
We addressed this using the c-Jun OE/+ mice examined earlier in experiments on aging 243 
(previous section; Fazal et al. 2017). The mice were 6-8 weeks old at the time of injury, 244 
corresponding to young mice in the study on aging. One and 3 week denervated distal 245 
stumps of c-Jun OE/+ and WT mice contained similar c-Jun protein levels. However, at 10 246 
weeks, when c-Jun had declined in WT mice, c-Jun was maintained in c-Jun OE/+ mice at 247 
levels similar to those at 1 week (Fig.4 A). This was confirmed by double label c-Jun/Sox10 248 
immunofluorescence (Fig.4 B). This showed similar c-Jun nuclear labeling in 1 week 249 
denervated stumps of WT and c-Jun OE/+ mice, while at 10 weeks, WT nerves showed a 250 
reduced number of c-Jun positive nuclei and decreased labeling intensity. This decrease 251 
was prevented in c-Jun OE/+ nerves.  252 
These experiments indicate that in 1-3 week cut nerves, the maximum capacity of Schwann 253 
cells to express c-Jun protein is already reached in the WT, both genotypes showing a 254 
similar 80-100 fold elevation after injury. During chronic denervation, these high expression 255 
levels fall substantially in WT nerves, but not in c-Jun OE/+ nerves. The c-Jun OE/+ mice 256 
can therefore be used to test whether the regeneration failure induced by chronic 257 
denervation is due to the failure to maintain high c-Jun protein levels. 258 
 259 
MAINTAINING C-JUN LEVELS DURING CHRONIC DENERVATION PREVENTS 260 
REGENERATION FAILURE 261 
Regeneration thorough chronically denervated distal stumps of WT and c-Jun OE/+ mice 262 
was compared using neuron back-filling. Acutely cut common peroneal nerves were sutured 263 
to acutely cut or 10 week denervated tibial nerves and allowed to regenerate for 2 weeks 264 
prior to application of Fluorogold retrograde tracer. In WT mice, the number of DRG neurons 265 
projecting through 10 week cut nerves was only about half that projecting through acutely cut 266 
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nerves. In 10 week cut c-Jun OE/+ nerves, however, this drop was not seen (Fig.5 A). 267 
Similar results were obtained for spinal cord motor neurons (Fig.5 B). Thus, both DRG and 268 
motor neurons regenerated as well through 10 week denervated c-Jun OE/+ nerves as they 269 
did through acutely cut WT nerves, suggesting that c-Jun OE/+ Schwann cells maintain their 270 
capacity to support regenerating neurons despite chronic denervation. In confirmation, 271 
regeneration into 10 week denervated distal stumps of the tibial nerve was examined with 272 
neurofilament staining, 1 week after the stumps were sutured to freshly cut peroneal nerves. 273 
Nearly 3 times more fibers were found in 10 week denervated c-Jun OE/+ nerves compared 274 
to 10 week denervated WT nerves (Fig.5 C). The number of fibers found in WT nerves after 275 
immediate repair is shown in Fig. 2 D. 276 
We verified that the back-filling paradigm worked as expected in c-Jun OE/+ mice. First, 277 
peroneal nerves in WT and c-Jun OE/+ mice were transected followed by immediate 278 
application of tracer to the injured proximal stump. The number of back-filled DRG and motor 279 
neurons in c-Jun OE/+ mice was similar to that in WT animals (Fig.5 D, E). This does not 280 
measure regeneration, but indicates that a comparable number of DRG and motor neurons 281 
project through the normal uninjured peroneal nerve in the two mouse lines. Second, 282 
although c-Jun levels in WT and c-Jun OE/+ mice diverge after 10 weeks of denervation, 283 
they are high, and similar, early after injury, when the capacity of WT nerves to support 284 
regeneration is optimal. In line with this, the regeneration support provided by WT and c-Jun 285 
OE/+ nerves was similar early after injury. Thus, in back-filling experiments no significant 286 
difference was seen between WT and c-Jun OE/+ mice in the numbers of DRG or motor 287 
neurons that regenerated through acutely transected distal stumps (immediate repair) when 288 
the tracer was applied 2 weeks after transection/repair. (Fig.5 F and not shown). Similarly, 289 
comparable numbers of back-filled motor neurons were obtained in WT and c-Jun OE/+ 290 
mice when back-filling was used to quantify regeneration 5 days after sciatic nerve crush 291 
(Fig.5 G).  292 
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Together, these experiments indicate that under the conditions prevailing in the distal stump 293 
of cut nerves, Schwann cells are unable to maintain high c-Jun levels in the long term. The 294 
resulting gradual reduction in c-Jun leads to deterioration of repair cell function, causing 295 
regeneration failure, a failure that can be corrected by restoring c-Jun levels. 296 
 297 
IMPROVED REGENERATION IN C-JUN OE+/- MICE IS UNLIKELY TO RELATE TO 298 
ALTERED CELL NUMBERS  299 
To test whether the differential regeneration rates could be due to altered cell numbers, 300 
Schwann cell, macrophage and fibroblast nuclei were counted in tibial nerves by electron 301 
microscopy.  302 
In experiments comparing young and aging animals, cells in the distal stump were counted 4 303 
days after nerve cut without regeneration. Schwann cell and macrophage numbers and 304 
density were similar irrespective of genotype or age (Fig.6 A-C). There was some decrease 305 
in fibroblast density in aged mice, but density and numbers were similar irrespective of 306 
genotype (Fig.6 D, E). In aged mice, transverse profiles of the tibial nerve were larger mainly 307 
because of increased endoneurial connective tissue, but no difference was seen between 308 
the genotypes (Fig.6 F). 309 
In the experiments on chronic denervation, cells were counted in the distal stumps 2 and 10 310 
weeks after cut without regeneration 5 mm from the injury site. There were ~250 Schwann 311 
cell nuclei in 2 week stumps, representing a ~2.5 fold increase from uninjured nerves (Fazal 312 
et al. 2017) (Fig.6 G). In the WT, Schwann cell numbers declined by ~30% during chronic 313 
denervation. This drop was prevented in c-Jun OE/+ nerves (Fig.6 G). The density of 314 
macrophages was similar irrespective of genotype or length of denervation (Fig.6 H), with 315 
numbers declining, irrespective of genotype, during chronic denervation (Fig.6 I). Two weeks 316 
after injury, fibroblast density in WT and c-Jun OE/+ mice was similar. Fibroblast density was 317 
elevated in 10 week stumps of WT, but not c-Jun OE/+, mice (Fig.6 J). Fibroblast numbers 318 
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remained unchanged between genotypes following denervation (Fig.6 K). Chronically 319 
denervated stumps of both genotypes had reduced nerve area, although this difference was 320 
less evident in c-Jun OE/+ nerves (Fig.6 L). 321 
These counts indicate that altered cell numbers are not a significant reason for improved 322 
regeneration in aged c-Jun OE/+ nerves. In chronically denervated nerves, the normal loss 323 
of Schwann cells in WT nerves is prevented in c-Jun OE/+ nerves. Even in 10 week WT 324 
stumps, however, cell numbers remain well above those in uninjured nerves (see 325 
Discussion). 326 
 327 
SHH SIGNALING SUPPORTS C-JUN EXPRESSION. 328 
Seeking mechanisms that promote c-Jun expression in denervated Schwann cells, we 329 
considered signaling by Shh, a gene that is not expressed in developing Schwann cells or in 330 
intact nerves, but strongly up-regulated in repair Schwann cells after injury (Lu et al. 2000; 331 
Zhou et al. 2000; Arthur-Farraj et al. 2012; Hsin-Pin et al. 2015).  First, we analysed Shh 332 
cKO mice, in which Shh is electively inactivated in Schwann cells and in which nerve 333 
ultrastructure appears normal as expected (J Svaren unpublished). We found that in the 334 
mutants, c-Jun protein and phosphorylated c-Jun were decreased in the distal stump of 7 335 
day transected sciatic nerve, (Fig.7 A, B). Levels of p75NTR protein, which is positively 336 
regulated by c-Jun in Schwann cells (Arthur-Farraj et al. 2012), were also reduced 7 days 337 
after injury in the mutants (Fig.7 C). Substantiating these observations, two Shh signaling 338 
agonists, SAG and purmorphamine, upregulated c-Jun protein in purified Schwann cell 339 
cultures (Fig.7 D, E).  This was confirmed using c-Jun/Sox10 double immunolabeling (Fig.7 340 
F). SAG also increased the expression of two c-Jun target genes that promote nerve 341 
regeneration Bdnf and Gdnf (Fig.8 A, B). Further, SAG promoted another effect of c-Jun, 342 
that of enhancing the elongated bi-or tri-polar shape in vitro that reflects the elongation and 343 
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branching of repair cells in vivo (Arthur-Farraj et al. 2012; Gomez-Sanchez et al. 2017) 344 
(Fig.8 C). 345 
After injury, Shh-dependent enhancement of c-Jun is likely to be mediated by Shh derived 346 
from Schwann cells, which are the major source of Shh in injured nerves. In support of such 347 
an autocrine hedgehog signaling loop, cyclopamine alone, which blocks cellular responses 348 
to Shh, down-regulated c-Jun protein and sharply suppressed c-Jun phosphorylation in 349 
cultured Schwann cells (Fig.8 D).  350 
Together these observations show that Shh promotes Schwann cell c-Jun expression in vitro 351 
and in vivo, and support the idea that injury triggers an autocrine Shh signaling loop to 352 
elevate c-Jun in repair cells. 353 
 354 
ANALYSIS OF GENE EXPRESSION IN DISTAL NERVE STUMPS OF WT AND C-JUN 355 
OE/+ MICE 356 
Young and aging mice. RNA sequence analysis was performed on uninjured and 3 day cut 357 
sciatic nerves of young (6-8 weeks) and aged (11-12 months) WT mice, and aged c-Jun 358 
OE/+ mice. Global gene expression was analysed comparing (i) uninjured nerves, (ii) 3d cut 359 
nerves, and (iii) the injury response (3d cut vs uninjured) in young and aged mice (Fig.9 - 360 
Figure Supplement 1 A). 361 
In uninjured WT nerves, out of 15,995 genes present, 1,477 genes were differentially 362 
expressed between young and aged mice. Of these, 1,154 were up-regulated and 323 363 
down-regulated in aging mice compared to young ones (FC >2; and FDR 0.05) 364 
(Supplementary File 1 A; Supplementary File 2 A).  We tested whether the 173 genes we 365 
previously identified as c-Jun regulated injury genes (Arthur-Farraj et al. 2012) were 366 
implicated in these age-dependent differences.  In the present data set, 138 of the 173 367 
genes were present (Supplementary File 3). They showed a strong enrichment among the 368 
1477 genes differentially expressed between young and aging mice (Fig.9 A).  369 
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In 3d cut WT nerves, of 17,334 genes present, 398 genes were differentially expressed 370 
between young and aging mice. Of these, 268 were up-regulated and 130 down-regulated in 371 
aging nerves (Supplementary File 1 B; Supplementary File 2 B). This gene set contains 372 
candidate genes responsible for the difference in regeneration support provided by young 373 
and aged Schwann cells (Painter et al. 2014 and present experiments).  In agreement with 374 
Painter et al. (2014), trophic factors such as GDNF, BDNF, NGF, erythropoietin and FGF 375 
were not among the differentially expressed genes. This suggests that expression of trophic 376 
factors often implicated in regeneration may not explain different regeneration between 377 
young and aged mice. The 138 c-Jun regulated injury genes (Supplementary File 3; Arthur-378 
Farraj et al. 2012) were highly enriched among the age-regulated genes (Fig.9 A).  379 
Examining the injury response (3 d cut vs uninjured nerve), 822 genes showed significant 380 
difference when young and aging WT mice were compared (Supplementary File 1 C; 381 
Supplementary File 2 C). The 138 c-Jun regulated injury genes were strongly enriched 382 
among these 822 genes (Fig.9 A). 383 
 384 
Gene set enrichment analysis (GSEA) on the above conditions showed that the 138 c-Jun 385 
genes were highly enriched among the genes down-regulated in aging uninjured nerves and 386 
in aging 3 day cut nerves (Fig. 9 - Figure Supplement 1 B, C).  When the injury response (3d 387 
cut vs uninjured) of young and aging WT mice was analysed, the strongest enrichment of c-388 
Jun genes was observed in genes upregulated in young nerves (Fig. 9 -  Figure Supplement 389 
1 D). While c-Jun genes are also upregulated in aged nerves post-injury, their enrichment 390 
was not as high as in young nerves. 391 
These correlations between enrichment of c-Jun regulated genes and Schwann cell age 392 
suggest that the c-Jun regulated repair program is disproportionately vulnerable during the 393 
aging process.  394 
Gene ontology (GO) analysis showed that in aged uninjured WT nerves, down-regulated 395 
genes were largely involved in lipid metabolism, as well as myelination, while genes involved 396 
16 
 
in the immune system were prominent among those up-regulated (Fig.9 B, C; reviewed in 397 
Melcangi et al. 1998; 2000; Büttner et al. 2018). Similar analysis of the injury response (3 398 
day cut vs uninjured) showed reduced activation of immune genes in aged WT nerves 399 
(Scheib and Höke 2016; Büttner et al. 2018). In aged nerves, MAPK pathways were also 400 
suppressed while lipid metabolism and Schwann cell differentiation genes were enhanced 401 
(Fig.9 D, E). Together this indicates suppressed Schwann cell reprogramming and repair cell 402 
activation in nerves of older WT mice. Testing the effects of enhanced c-Jun expression on 403 
the aged injury response, we found that pathways associated with protein processing and 404 
maturation were up-regulated in aged c-Jun OE/+ nerves compared with aged WT nerves 405 
(Fig.9 F).  406 
To further determine genes that may contribute to the restoration of regeneration in aged c-407 
Jun OE/+ mice, the injury responses in young and aged WT mice and aged c-Jun OE/+ mice 408 
were compared (Fig.9 G). Of particular interest are the 303 genes that show significant injury 409 
response in young WT mice but not in aging WT mice, but are again significantly regulated 410 
by restoring c-Jun to youthful levels in aging c-Jun OE/+ mice (Supplementary File 2 D). 411 
Among the 138 c-Jun regulated genes, we looked for a correlation between a failure and 412 
restoration of gene expression on the one hand, and failure and restoration of regeneration 413 
on the other. In 3 day cut aged WT nerves, where regeneration fails, 16 c-Jun regulated 414 
genes were differentially expressed compared to 3 day cut young WT nerves. Four of these, 415 
Aqp5, Gpr37L1, Igfbp2, and Olig1, were restored in aged c-Jun OE/+ nerves, where 416 
regeneration is restored (Fig 9 H). Thus, in aging mice, both regeneration failure and the 417 
expression defect of these four genes was restored to levels in young mice, by elevating c-418 
Jun levels.  419 
Chronic denervation. Gene expression was examined in uninjured nerves and in 1 and 10 420 
week cut sciatic nerves of WT and c-Jun OE/+ mice (Fig. 10 - Figure Supplement 1 A). 421 
Expression of 1581 genes changed significantly during chronic denervation (Supplementary 422 
File 4; Supplementary File 2 E).  In 10 week cut nerves, 601 of these genes were down-423 
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regulated, including genes associated with repair cells such as Gdnf, Shh and Ngfr, while 424 
980 genes were up-regulated. The 138 c-Jun regulated genes showed a highly significant 425 
5.8 fold enrichment (p=2.2x10-16) among the 1581 genes regulated during chronic 426 
denervation. GSEA enrichment analysis showed that c-Jun genes were some of the most 427 
down-regulated genes during chronic denervation. (Fig.10 - Figure Supplement 1 B).   428 
GO analysis showed that the major genes down-regulated during chronic denervation in WT 429 
nerves involved the cell cycle, DNA replication and repair. Glial cell differentiation genes and 430 
MAPK pathways, potential activators of c-Jun, were also suppressed (Fig.10 A). Chronic 431 
denervation involved a prominent up-regulation of neuro-glia signaling genes (chiefly related 432 
to GABA and adrenergic signalling), but also negative regulators of differentiation, Notch and 433 
cAMP signaling (Fig.10 B). To test the effects of maintaining c-Jun protein levels during the 434 
10 week chronic denervation, we identified genes differentially expressed between 10 week 435 
cut WT and c-Jun OE/+ nerves (Fig.10 C). This showed strong up-regulation, in c-Jun OE/+ 436 
mice, of pathways involved in PNS and Schwann cell development and differentiation.  437 
To further determine genes that may contribute to the restoration of regeneration in aged c-438 
Jun OE/+ mice, the injury response in the three situations analysed in the regeneration 439 
experiments, WT 1 week, WT 10 weeks and c-Jun OE/+ 10 weeks, was compared (Fig.10 440 
D). A point of interest are the 227 genes that showed an injury response in WT 1 week 441 
nerves and in c-Jun OE/+ 10 week nerves, both of which show fast regeneration, but no 442 
injury response in WT 10 week nerves, where regeneration is slow (Supplementary File 2 F). 443 
As when studying aged mice, we looked among the 138 c-Jun regulated injury genes for 444 
candidates involved in decreased regeneration in 10 week cut WT nerves and the 445 
restoration of regeneration in 10 week cut c-Jun OE/+ nerves. Fifty of the 138 genes 446 
changed expression during chronic denervation in WT nerves, where regeneration is poor. In 447 
chronically denervated c-Jun OE/+ nerves, where regeneration is restored, expression levels 448 
were restored, completely or partially, in the case of five of these genes, Cxcl5, Egfl8, 449 
Gas213, Megf10 and Pcdh20 (Fig.10 E). These correlations provide a basis for considering 450 
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these genes as candidates down-stream of c-Jun for involvement in the restoration of 451 
regeneration in chronically denervated nerves of c-Jun OE/+  452 
 453 
                                                          DISCUSSION  454 
The present results indicate that reduced expression of c-Jun is an important factor in the 455 
repair cell failures seen during aging and chronic denervation. In both situations, Schwann 456 
cells of injured nerves fail to achieve or maintain high c-Jun levels, and in both cases, 457 
correction of c-Jun expression restores regeneration deficits. This highlights the importance 458 
of c-Jun in the function of repair Schwann cells, provides a common molecular link between 459 
two apparently unrelated problems in nerve repair, and points to manipulation of c-Jun 460 
regulated pathways as a potential route for improving the outcome of nerve injuries. 461 
By using neuron back-filling this study provides a direct quantitative measure of neuronal 462 
regeneration capacity in vivo and how this is controlled by Schwann cell c-Jun levels. It also 463 
opens new questions that remain to be investigated.  In particular, to what extent does c-Jun 464 
in Schwann cells determine other factors that are also important for repair. This includes the 465 
length of time neurons are able to sustain axon growth after injury, sprouting, axonal 466 
misrouting, targeting and synapse re-formation. 467 
A previously identified gene set regulated by c-Jun in injured nerves (Arthur-Farraj et al. 468 
2012), was found to be highly enriched among the genes affected by aging or chronic 469 
denervation in WT mice. The expression of a small group of genes was also positively 470 
correlated both with c-Jun levels and regeneration, suggesting that their role in Schwann 471 
cells or other cells in the nerve merits further study. In aging mice this encompasses Aqp5, 472 
Gpr37L1, Igfbp2 and Olig1, all of which have been studied in glial cells. Igfbp2 promotes 473 
phosphorylation of Akt, a pathway that is linked to Schwann cell proliferation and 474 
differentiation (reviewed in Ma et al. 2015; Boerboom et al. 2017; Jessen and Arthur-Farraj 475 
2019). Gpr37L1 is a receptor for prosaposin and prosapeptide (Meyer et al. 2013). In 476 
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Schwann cells prosapeptide phosphorylates MAPK (Hiraiwa et al. 1997) and prosaposin is 477 
secreted after nerve injury, facilitating regeneration (Hiraiwa et al. 1999). In experiments on 478 
chronic denervation this gene group encompasses Cxcl5, Egfl8, Gas2I3, Megf10 and 479 
Pcdh20. All of these genes were previously shown to be up-regulated in Schwann cells after 480 
injury (Zhang et al. 2011; Tanaka et al. 2013; Weiss et al. 2016; reviewed in Ma et al. 2016; 481 
Brosius Lutz et al. 2017).  Cxcl5 activates STAT3 (Zhang et al. 2011), a transcription factor 482 
that we have shown to be important for maintaining repair cells during chronic denervation 483 
(Benito et al. 2017). Gas2I3 has a role in the cell cycle, and Megf10 in phagocytosis (Wolter 484 
et al. 2012; Chung et al. 2013).  485 
Since c-Jun levels in injured nerves are a major determinant of effective repair, it is important 486 
to identify signals that control c-Jun expression. The present results suggest that Shh has a 487 
role in this process. In injured nerves of Shh cKO mice, there is reduced c-Jun activation and 488 
diminished Schwann cell expression of the c-Jun target p75NTR. In purified Schwann cells, 489 
application of Shh elevates c-Jun, while cyclopamine alone suppresses c-Jun. Shh also 490 
promotes Schwann cell elongation. Further, during chronic denervation, Shh expression, like 491 
that of c-Jun, is substantially reduced. Previous work also implicates Shh signaling in repair. 492 
Shh is up-regulated in Schwann cells after injury (Hashimoto et al. 2008; Arthur-Farraj et al. 493 
2012; Yamada et al. 2018), and exposure to Shh improves nerve regeneration in various 494 
settings (Pepinsky et al. 2002; Bond et al. 2013; Martinez et al. 2015; Yamada et al. 2018). 495 
Inhibition of Shh signaling reduces Schwann cell expression of BDNF, motor neuron survival 496 
after injury and axon regeneration (Hashimoto et al. 2008; Yamada et al. 2020), and a 497 
molecular link between Shh signaling and Jun activation has been established in various cell 498 
lines (Laner-Plamberger et al. 2009; Kudo et al. 2012). Further in vivo experiments using 499 
Shh cKO mice as well as Shh agonists and antagonists are needed to conclusively 500 
determine the involvement of Shh in regeneration. At present, however, the data presented 501 
here and previous work are consistent with the existence of an autocrine Shh signaling loop 502 
activated by injury to promote expression of c-Jun and the repair cell phenotype. 503 
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In c-Jun OE/+ mice, we considered whether restoration of c-Jun levels altered cell numbers, 504 
thus promoting regeneration. In aging mice, the results appear to exclude this, since cell 505 
numbers in the mutant and the WT are similar. During chronic denervation, Schwann cell 506 
numbers remain constant in c-Jun OE/+mice, but fall by about 30% in the WT. Since there is 507 
now evidence that Schwann cell proliferation may not be essential for regeneration, contrary 508 
to common assumptions, the relationship between cell numbers and repair is currently 509 
unclear (Kim et al. 2000; Atanasoski et al. 2001; Yang et al. 2008; for discussion see Jessen 510 
and Mirsky 2019). Even in WT mice, cell number after chronic denervation remains nearly 511 
twice that in uninjured nerves. It is therefore unlikely that the changes in Schwann cell 512 
numbers are the key reason for the reduced regeneration support provided by 10-week cut 513 
WT stumps, or the increase in support provided by 10 week cut c-Jun OE/+ stumps.  514 
The degree of reduction in transverse nerve area after chronic denervation could also affect 515 
repair. However, the area of 10 week cut c-Jun OE/+ nerves, while increased compared to 516 
10 week cut WT, remains ~50% smaller than that of 2-week cut WT nerves. Nevertheless, 517 
regeneration through these nerves is similar. The relationship between nerve area and 518 
regeneration in these experiments may therefore not be straightforward.  519 
During longer denervation times, cell loss and nerve shrinking will increasingly impede 520 
repair. These slow, atrophic changes, likely involving regulation of cell death and 521 
proliferation, have not been extensively studied, although STAT3 has recently be implicated 522 
in the long term maintenance of repair cells (Benito et al. 2017). Previously, c-Jun was 523 
shown to influence both apoptosis and proliferation in repair Schwann cells (Parkinson et al. 524 
2001; 2004; 2008), but the particular way in which c-Jun levels determine nerve atrophy 525 
remains to be determined.          526 
       It has become clear that the injury-induced reprogramming of Schwann cells to cells 527 
specialized to support nerve regeneration is regulated by dedicated mechanisms, including 528 
c-Jun, STAT3, merlin and H3K27 trimethylation-related epigenetic controls, that operate 529 
selectively in repair cells, and have a relatively minor or undetectable function in Schwann 530 
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cell development (reviewed in Jessen and Mirsky 2019). The present work provides 531 
evidence that an impairment of one of these mechanisms, c-Jun, is a major contributor to 532 
two major categories of regeneration failure, aging and chronic denervation. It will be 533 
important to extend this study to other regulators of repair cells as a basis for developing 534 
molecular interventions for promoting repair in the PNS.    535 
        536 
                                                       537 
 538 
                                                               METHODS  539 
 540 
 541 
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Transgenic mice 549 
 550 
Animal experiments conformed to UK Home Office guidelines under the supervision of 551 
University College London (UCL) Biological Services under Protocol No. PPL/70/7900. Mice 552 
were generated to overexpress c-Jun selectively in Schwann cells as described (Fazal et al. 553 
2017). Briefly, female R26c-Junstopf mice carrying a lox-P flanked STOP cassette in front of 554 
a CAG promoter-driven c-Jun cDNA in the ROSA26 locus, were crossed with 555 
male MpzCre+/− mice (Feltri et al. 1999). This generated MpzCre+;R26c-Junstopff/+  556 
 mice, referred to here as c-Jun OE/+ mice. MpzCre−/Cre− littermates were used as controls. 557 
Shh-floxed mice, referred to as Shh cKO mice, carrying loxP sites flanking exon 2 of the Shh 558 
gene were obtained from the Jackson Laboratory (Jax®, stock# 004293), and bred to MpzCre 559 
mice (Feltri et al., 1999). Experiments used mice of either sex on the C57BL/6 background.  560 
Genotyping  561 
DNA was extracted from ear notches or tail tips using the Hot Sodium Hydroxide and Tris 562 
method (HotSHot; (Truett et al. 2000). Tissue was incubated in HotSHot buffer (25 mM 563 
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NaOH and 0.2 mM disodium EDTA, pH 12) at 95°C for 1h. The reaction was neutralized with 564 
neutralizing buffer (40 mM Tris-HCl, pH 5). DNA was then added to the PCR mastermix with 565 
primers for the Mpz-Cre transgene: 5′-GCTGGCCCAAATGTTGCTGG-3′ and 566 
5′CCACCACCTCTCCATTGCAC-3′ (480 bp band). 567 
Surgery 568 
For short-term time points (<1 week) and crushes, the sciatic nerve was exposed and cut or 569 
crushed (at 3 rotation angles) at the sciatic notch. For Western blot, immunofluorescence 570 
and mRNA investigations into chronic denervation (>1 week) the sciatic nerve was cut and 571 
the proximal stump was reflected back and sutured into muscle to prevent regeneration. The 572 
nerve distal to the injury was excised for analysis at various time points. Contralateral 573 
uninjured sciatic nerves served as controls. To examine the effects of chronic denervation, 574 
the nerve branches of the sciatic nerve were individually separated. (Fig. 2, Figure 575 
Supplement 1). The tibial nerve was cut and both proximal and distal stumps were reflected 576 
and sutured into muscle. Either immediately or following 10 weeks of chronic denervation, 577 
the distal tibial nerve stump was cut from the muscle and sutured to the freshly transected 578 
common peroneal nerve 579 
Retrograde labelling with Fluorogold 580 
To examine regeneration, following nerve crush or repair, the nerve was cut distal to the 581 
original injury site and exposed to 4% Fluorogold for 1 hour (Catapano et al. 2016; Fig. 1, 582 
Figure Supplement 1). The spinal cord and L4 DRG were removed following perfusion 1 583 
week post-labeling. Labeled cells in all of the spinal cord sections (50μm) were counted and 584 
the Abercrombie correction was applied to compensate for double counting (Abercrombie 585 
1946). To avoid double counting, cells in every fifth DRG section (20μm) were counted.  586 
Schwann cell cultures  587 
Rat Schwann cells were cultured as described (Brockes et al. 1979). Briefly, sciatic nerves 588 
and brachial plexuses were digested enzymatically with collagenase and trypsin and 589 
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cultured on laminin and PLL coated plates in DMEM, 2% FBS, 10ng/ml NRG-1, 2μM 590 
forskolin and penicillin/streptomycin. Under experimental conditions, cultures were 591 
maintained in defined medium (DMEM and Ham's F12 (1:1), transferrin (100 pg/ml), 592 
progesterone (60 ng/ml), putrescine (16 pg/ml), insulin (5 μg/ml), thyroxine (0.4 μg/ml), 593 
selenium (160 ng/ml), triiodothyronine (10.1 ng/ml), dexamethasone (38 ng/ml), glucose (7.9 594 
mg/ml), bovine serum albumin (0.3 mg/ml), penicillin (100 IU/ml), streptomycin (100 IU/ml), 595 
and glutamine (2 mM) with 0.5% serum (Jessen et al., 1994; Meier et al. 1999).  596 
Antibodies  597 
Immunofluorescence antibodies: c-Jun (Cell Signaling Technology, rabbit 1:800), Sox10 598 
(R&D Systems, goat 1:100), CGRP (Peninsula, rabbit 1:1000), Neurofilament (Abcam, rabbit 599 
1:1000) donkey anti-goat IgG (H+L) Alexa Fluor 488 conjugate (Invitrogen, 1:1000), Cy3 600 
donkey anti-rabbit IgG (H+L) (Jackson Immunoresearch, 1:500). 601 
Antibodies used for Western blotting: c-Jun (Cell Signaling Technology, rabbit 1:1000), p75 602 
NTR (Millipore, rabbit 1:1000), serine 63 phosphorylated c-Jun (Cell Signaling Technology, 603 
rabbit 1:1000), GAPDH (Sigma-Aldrich, rabbit 1:5000), calnexin (Enzo Life Sciences, rabbit 604 
1:1000), anti-rabbit IgG, HRP-linked (Cell Signaling Technology, 1:2000).  605 
Immunofluorescence  606 
For immunofluorescence experiments on cultured cells, 5000 Schwann cells were plated in a 607 
35μl drop on a PLL laminin coated coverslip. Cells were topped up with defined medium 608 
after 24 hours. At the experimental end point, cells were washed 2x with 1x PBS. Cells were 609 
fixed with 4% PFA for 10 minutes. Cells were then washed for 5 minutes in 1x PBS. Fresh 610 
PBS was added to the wells and the lid was parafilm sealed. Dishes were stored at 4°C until 611 
use. 612 
Nerve samples were fresh frozen during embedding in OCT. Cryosections were cut at 10μm. 613 
Sections were fixed in 100% acetone (Sox10/c-Jun double-labeling, 10 minutes at -20°C) or 614 
4% PFA (10 minutes at room temperature).  615 
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For immunofluorescence, all samples were washed 3x in 1x PBS and blocked in 5% donkey 616 
serum, 1% BSA, 0.3% Triton X-100 in PBS. Samples were incubated with primary antibodies 617 
in blocking solution overnight at 4°C. Sox10/c-Jun double-labeling was performed overnight 618 
at room temperature. Samples were washed and incubated with secondary antibodies and 619 
DAPI to identify cell nuclei (Thermo Fisher Scientific, 1:40,000) in PBS for 1 hour at room 620 
temperature. Samples were mounted in fluorescent mounting medium (Citifluor). 621 
Images were taken on a Nikon Labophot 2 fluorescence microscope. Cell counts were 622 
performed in ImageJ or directly from the microscope. Comparable images have been equally 623 
adjusted for brightness/contrast. In some cases (Figs 1,3 and 4), images of whole nerve 624 
profiles have been generated by stitching together multiple images.  625 
Western Blotting 626 
Nerves were dissected and snap frozen in liquid nitrogen. For protein extraction, nerves 627 
were placed in 2ml graduated skirted tubes with 9 10B lysing beads with 75ml lysis buffer 628 
(1M Tris-HCl pH 8, 5M NaCl, 20% Triton X-100, 5mM EDTA) and homogenized using a 629 
Fastprep fp120 homogeniser. Samples were run twice at speed 6 for 45 seconds. Lysates 630 
were then centrifuged at 13000rpm for 2 minutes at 4°C to pellet the debris. The supernatant 631 
was transferred to a new 1.5ml Eppendorf tube and centrifuged at 13000rpm for 2 minutes at 632 
4°C. The supernatant was transferred to a new 1.5ml Eppendorf tube and the protein extract 633 
was stored at -80°C. 634 
For protein studies on cultured cells, 1 x 106  purified Schwann cells were plated in a 35mm 635 
dish in defined medium for 48 hours. At the time of extraction, the cultures were washed 2x 636 
with 1x PBS and incubated with 100µl cell lysis buffer (T-PER Tissue Protein Extraction 637 
Reagent, Halt protease & phosphatase inhibitor cocktail (1:100) Thermo Fisher Scientific). 638 
Cells were physically detached from dishes using a cell scraper. The cell lysate was 639 
collected and kept on ice in a 1.5ml Eppendorf tube. Lysate was spun for 2 minutes at 640 
1000rpm to pellet the debris. The supernatant was transferred to a fresh Eppendorf tube and 641 
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spun for a further 2 minutes at 1000rpm. The supernatant was transferred to a new 1.5ml 642 
Eppendorf tube and stored at -80°C until use. 643 
Protein was diluted in the appropriate lysis buffer and 5x Laemmli buffer at a working 644 
concentration of 1x. Samples were heated to 95°C for 5 minutes to denature the protein. 645 
10µg protein was loaded per well on 8% acrylamide gels with prestained standard molecular 646 
weight markers (PageRuler prestained protein ladder; Thermo Fisher Scientific) and run at 647 
60mV for 3 hours using the mini Protean II gel electrophoresis apparatus (Bio-Rad 648 
Laboratories). Protein was transferred to a nitrocellulose membrane (Hybond ECL; 649 
Amersham Biosciences) using a semi-dry transfer system (Bio-Rad Laboratories) at 25mV 650 
for 45 minutes. Membranes were briefly stained with Ponceau S (Sigma Aldrich) to 651 
determine that the transfer has been successful and that equal levels of protein had been 652 
loaded in the gel. Membranes were briefly washed in ddH2O to remove excess Ponceau and 653 
blocked in 5% milk/TBS-T for 1 hour with shaking at room temperature. Membranes were 654 
then incubated with appropriate antibodies in heat sealable polyethylene bags and were 655 
incubated overnight at 4°C on a rotatory wheel. Membranes were washed 3x for 10 minutes 656 
in 1x TBS-T then incubated with the appropriate secondary antibody in heat sealable 657 
polyethylene bags, rotating for 1 hour at room temperature. Membranes were washed 3x for 658 
10 minutes in 1x TBS-T before developing. For development of GAPDH, membranes were 659 
incubated with ECL (Amersham) for 1 minute and developed on a Bio-Rad Chemidoc 660 
machine. For the development of all other antibodies, membranes were incubated with ECL 661 
prime (Amersham) for 5 minutes then developed. Membranes were automatically exposed to 662 
prevent saturation. Blots were analysed and densitometric quantification was performed 663 
using Bio-Rad Imagelab. Protein levels were determined by normalising the protein of 664 
interest against the house keeping protein (GAPDH or calnexin). All blots were then 665 
normalized to one sample (e.g 1 week after injury, control cells) to account for any difference 666 
between each blot. Each experiment was performed at least 3 times with fresh samples. 667 
Representative images are shown. 668 
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Electron microscopy 669 
Nerves were fixed in 2.5% glutaraldehyde/2% paraformaldehyde in 0.1 M cacodylate buffer, 670 
pH 7.4, overnight at 4°C. Post-fixation in 1% OsO4 was performed before nerves were 671 
embedded in Agar 100 epoxy resin. Transverse ultrathin sections from adult (P60) or aged 672 
(P300) tibial nerves or from injured distal stumps of adult sciatic nerves at various times after 673 
injury were taken 5mm from the sciatic notch and mounted on film (no grid bars). Images 674 
were examined using a Jeol 1010 electron microscope with a Gatan camera and software. 675 
Images were examined and photographed at 8000× or 15,000x. The nerve area was 676 
measured from photographs taken at 200× magnification. Schwann cells and macrophages 677 
and fibroblasts were identified by standard ultrastructural criteria (e.g. Reichert et al. 1994). 678 
Schwann cell, macrophage and fibroblast nuclei were counted in every field, or every 679 
second, third or fourth field, depending on the size of the nerve, and multiplied by the 680 
number of fields to generate totals. 681 
qPCR 682 
RNA from rat Schwann cell cultures or mouse nerve tissue was extracted using an RNeasy 683 
Micro Extraction Kit (Qiagen). RNA quality and concentration was determined after 684 
extraction using a nanodrop 2000 machine (Thermo). 1μg of RNA was converted to cDNA 685 
using SuperScriptTM II Reverse Transcriptase (Invitrogen) as per the manufacturer’s 686 
instructions. Samples were run with PrecisionPLUS qPCR Mastermix with SYBR Green 687 
(Primerdesign) with primers as described in Benito et al. (2017). Ct values were normalized 688 
to housekeeping gene expression (GAPDH and calnexin). 689 
  Primer Sequence 5´- 3´ 
Bdnf Fwd TCATACTTCGGTTGCATGAAGG 
Bdnf Rev AGACCTCTCGAACCTGCCC 
c-Jun Fwd (Cells) AATGGGCACATCACCACTACAC 
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c-Jun Rev (Cells) TGCTCGTCGGTCACGTTCT 
c-Jun Fwd (Tissue) CCTTCTACGACGATGCCCTC 
c-Jun Rev (Tissue) GGTTCAAGGTCATGCTCTGTTT 
Gdnf Fwd GATTCGGGCCACTTGGAGTT 
Gdnf Rev GACAGCCACGACATCCCATA 
Calnexin Fwd CAACAGGGGAGGTTTATTTTGCT 
Calnexin Rev TCCCACTTTCCATCATATTTGGC 
GAPDH Fwd AGGTCGGTGTGAACGGATTTG 
GAPDH Rev TGTAGACCATGTAGTTGAGGTCA 
 690 
Statistical analysis  691 
Results are expressed as mean ± SEM. Statistical significance was estimated by 692 
Student's t test, one-way ANOVA or two-way ANOVA with appropriate post hoc tests. 693 
A p value <0.05 was considered as statistically significant. Statistical analysis was performed 694 
using GraphPad software.  695 
Library preparation  696 
RNA was extracted using a RNeasy lipid tissue kit with an in column DNase step (Qiagen). 697 
Chronically denervated and uninjured nerves were pooled, 2 per n. Acutely denervated 698 
nerves were not pooled using 1 nerve per n. The library was prepared using the Kapa mRNA 699 
Hyper Prep kit (Roche) with 100ng RNA and 15 cycles of PCR enrichment. The assay is 700 
(first) stranded (dUTP method).  701 
Sequencing  702 
Sequencing was performed in a pooled NextSeq 500 run using a 43bp paired end protocol 703 
(plus a 6bp index read). Sequencing reads (in fastq format) were aligned to the hg38 704 
reference sequence using STAR v2.5.3 (Dobin et al. 2013). Samtools version 1.2 and Picard 705 
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tools version 1.140 were used to process alignments (Li et al. 2009)’  Aligned reads were 706 
filtered for mapq _ 4 i.e. uniquely mapping reads, and putative PCR duplicates were 707 
removed. featureCounts was used to perform read summarization (Liao et al. 2014).  708 
Data Analysis  709 
Expression analysis was carried out using R version 3.5.1. Differential gene expression was 710 
analysed using edgeR (Robinson et al. 2010). Genes with both an absolute log2 fold change 711 
> 2.0 and FDR < 0.05 were identified as being significantly differentially expressed. Principal 712 
Component Analysis (PCA) showed that injury status was the dominant source of variation 713 
in both data sets (Fig. 7 Figure Supplement 1 A; Fig. 8 Figure Supplement 1A). Enrichment 714 
of c-Jun regulated genes was investigated using Fisher one-sided exact tests and gene set 715 
enrichment analysis (GSEA; Subramanian et al. 2005). Gene ontology (GO) analysis was 716 
used to examine gene enrichment of all significantly differentiated genes using the 717 
PANTHER classification system (Mi et al. 2013).  718 
                            719 
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 1016 
                              LEGENDS FOR FIGURES AND FIGURE SUPPLEMENTS 1017 
Figure 1; Figure Supplement 1: 1018 
 Restoring Schwann cell c-Jun protein reverses the age-related decline in nerve 1019 
regeneration.  1020 
(A) Representative Western blots of c-Jun in young and aging WT nerves and aging c-Jun 1021 
OE/+ nerves 3 days post injury. The graph shows densitometric quantitation of the Western 1022 
blots. c-Jun up-regulation is impaired in WT aged nerves but restored in aged c-Jun OE/+ 1023 
nerves. Data are normalised to young WT 3 days post cut, *p<0.05, **p<0.005, ns, non-1024 
significant. Young UI WT n=6, n=5 for all other experimental groups. (B) RTqPCR analysis of 1025 
3 day cut nerves. Data normalised to young WT 3 days post cut. **p<0.005, ns, non-1026 
significant, n=4. (C) Representative images showing immunofluorescence of c-Jun in double 1027 
labeling with Schwann cell nuclear marker Sox10 in sections of the distal nerve stump in 1028 
young and aging WT and aging c-Jun OE/+ mice 3 days post cut. In the graph, the results 1029 
are quantitated by cell counting. In aging WT Schwann cells, c-Jun is reduced, but elevated 1030 
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to youthful levels in aging c-Jun OE/+ Schwann cells. ***p<0.001, ns, non-significant. n=3 for 1031 
each experimental group. (D) Representative images showing Fluorogold-labeled sensory 1032 
neurons in L4 DRGs of aging WT and c-Jun OE/+ mice 1 week post back-filling following a 4 1033 
day crush injury. The graph shows quantitation by cell counting. There is an age-related 1034 
decrease in back-filled neurons in WT samples (p=0.0309), while the high number of 1035 
regenerating neurons in young WT mice is maintained in aging c-Jun OE/+ DRGs 1036 
(p=0.0211).  Unpaired Student`s t-test. Young WT n=6, Aging WT n=5, Aging c-Jun OE/+ 1037 
n=6. (E) Representative images of Fluorogold-labeled motor neurons in aging WT and c-Jun 1038 
OE/+ mice 1 week post back-filling following a 4 day crush injury. The graph shows 1039 
quantitation of the results. Counts of labeled motor neurons mirror those of sensory neurons 1040 
since in WT mice, but not in c-Jun OE/+ mice, the number of back-labeled motor neurons 1041 
decreases with age. ***p<0.001, **p<0.005, n=6 for all experimental groups. (F) Counts of 1042 
calcitonin gene-related peptide (CGRP)+ regenerating axons 3mm from crush injury of the 1043 
sciatic nerve of young and aged WT mice, and of aging c-Jun OE/+ mice. ****p<0.0001, 1044 
***p<0.001. Young WT n=5, aging WT and c-Jun OE/+ n=6. All numerical data are analysed 1045 
by one-way ANOVA with Tukey’s multiple comparison test and represented as means ± 1046 
SEM. All scale bars: 100μm. 1047 
Figure 2; Figure Supplement 1:  1048 
The mouse model of chronic denervation  1049 
(A) Analysis of RNA sequencing data showing decrease in gene expression during chronic 1050 
denervation. (B) Representative Western blot showing p75NTR expression in uninjured (UI) 1051 
nerves and distal nerve stumps following 3 days, and 1, 3, 6, 8 and 10 weeks of denervation. 1052 
The graph shows quantitation of the results.  P75NTR peaks 1 week after injury and 1053 
gradually declines during prolonged denervation. Data normalized to 1 week after injury. 1054 
One-way ANOVA with Dunnett's multiple comparison test; **p<0.005, ***p<0.001. n=4. (C) 1055 
Counts of back-filled Fluorogold labeled regenerating motor neurons following immediate 1056 
repair or chronic 10 week denervation show a decrease in motor neuron regeneration into 1057 
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chronically denervated stumps. Unpaired Student’s t-test; **p= 0.0020. n=6 for each time 1058 
point. (D) Counts of neurofilament+ axons mirrors the decline in regeneration observed with 1059 
chronic denervation shown in C. Counts were performed on transverse sections taken 3mm 1060 
from the repair site1 week after repair. Unpaired Student’s t-test; ****p<0.0001. Immediate 1061 
repair n= 5, chronic denervation n=4. (E) Counts of back-filled Fluorogold-labeled motor 1062 
neurons showing similar numbers of regenerating neurons following immediate repair or 1063 
repair after 1 week of denervation. Unpaired Student’s t-test; p=0.9. n=3. All numerical data 1064 
represented as means ± SEM.  1065 
Figure 3: 1066 
 c-Jun declines in the distal nerve stump during chronic denervation and long-term 1067 
culture 1068 
 (A) Representative Western blot of c-Jun in WT uninjured (UI) nerves and distal stumps 1069 
following 3 days and 1, 3, 6, 8 and 10 weeks of denervation. The graph quantitates the 1070 
results, showing an initial increase followed by a decline in c-Jun levels. Data normalized to 1071 
1 week post injury. One-way ANOVA with Dunnett’s multiple comparisons test; *p<0.05, 1072 
**p<0.005, ****p<0.0001. n=5. (B) Representative Western blot comparing c-Jun expression 1073 
1 week after injury in WT and c-Jun cKO mice. The graph quantitates the results, showing 1074 
up-regulation of c-Jun in WT nerves but not in c-Jun cKO nerves, demonstrating that the c-1075 
Jun up-regulation after injury is Schwann cell specific. Data normalized to WT 1 week post 1076 
injury. Two-way ANOVA with Sidak’s multiple comparison test; ****p<0.0001. n=5. (C) 1077 
Representative immunofluorescence images of c-Jun/Sox10 double labeling in transverse 1078 
sections of the distal stumps 1 and 10 weeks after cut. Boxed areas shown at higher 1079 
magnification in right hand panels. Note loss of c-Jun protein from Schwann cell nuclei at 10 1080 
weeks (arrows). (D) Representative Western blot of c-Jun and p75NTR in Schwann cell 1081 
cultures after 2 or 9 passages. The results are quantitated in the graphs, showing decline in 1082 
c-Jun and p75NTR with time in vitro. Data normalised to passage 2.  Unpaired Student’s t-1083 
test; **p=0.0023, ***p=0.0007. n=6 for c-Jun, n=7 for p75NTR(E) qPCR analysis showing 1084 
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reduction in c-Jun mRNA in Schwann cultures following 9 passages. Data normalized to 1085 
passage 2. Unpaired Student’s t-test; *p=0.0299. n= 3. (F) c-Jun/Sox10 double labeling with 1086 
nuclear marker DAPI after 2 or 9 passages. Note decline of nuclear c-Jun in passage 9 cells. 1087 
All numerical data represent means ± SEM. 1088 
Figure 4: 1089 
 c-Jun expression is maintained in c-Jun OE/+ Schwann cells during chronic 1090 
denervation  1091 
(A) Representative Western blots of c-Jun in WT and c-Jun OE/+ distal stumps after 1, 3 and 1092 
10 weeks of denervation. The results are quantitated in the graph. In contrast to WT nerves, 1093 
c-Jun OE/+ nerves maintain consistent levels of c-Jun during 10 week chronic denervation. 1094 
Data normalized to WT 1 week post injury. Two-way ANOVA with Sidak’s multiple 1095 
comparisons test; *p<0.05. n=5. (B) Representative images showing c-Jun/Sox10 double 1096 
immunofluorescence in transverse sections of WT and OE/+ uninjured and injured distal 1097 
stumps. The graph shows quantitation by cell counting. The c-Jun labeling of Sox10 positive 1098 
nuclei in the two genotypes is comparable at 1 week, but reduced at 10 weeks in WT nerves 1099 
only. Two-way ANOVA with Tukey’s multiple comparison test; *** P<0.001. n= 3. All 1100 
numerical data represented as means ± SEM, all scale bars: 100µm.  1101 
Figure 5: 1102 
 The regenerative capacity of c-Jun OE/+ nerves is maintained during chronic 1103 
denervation 1104 
 (A) Representative images showing Fluorogold-labeling of neurons in L4 DRGs of WT and 1105 
c-Jun OE/+ mice after 2 weeks of regeneration into acutely transected (immediate repair) or 1106 
chronically denervated (10 weeks) distal stumps. Quantification by cell counting is in the 1107 
graph. The number of back-filled DRG neurons following regeneration through chronically 1108 
denervated WT stumps was reduced, but maintained after regeneration through chronically 1109 
denervated c-Jun OE/+ stumps. One-way ANOVA with Tukey’s multiple comparison test; 1110 
**p<0.005, *p<0.05, ns non-significant. WT immediate repair and chronic denervation n= 6, 1111 
OE/+ chronic denervation n=8. (B) Representative images showing Fluorogold- labeling of 1112 
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back-filled motor neurons in WT and c-Jun OE/+ mice after 2 weeks of regeneration into 1113 
acutely transected (immediate repair) or chronically denervated distal stumps. Quantification 1114 
is in the graph, showing that compared to immediate repair, the number of labeled neurons 1115 
is reduced after regeneration through chronically denervated WT stumps, but not after 1116 
regeneration through chronically denervated c-Jun OE/+ stumps. One-way ANOVA with 1117 
Tukey’s multiple comparison test; **p<0.005. WT immediate repair and chronic denervation 1118 
n= 6, c-Jun OE/+ chronic denervation n=8. (C) Counts of neurofilament+ immunofluorescent 1119 
fibers in the distal stump 1 week after repair following chronic denervation of WT and c-Jun 1120 
OE/+ nerves. In parallel experiments, the number of neurofilament+  fibers in WT nerves 1121 
after immediate repair was about 200 (see Fig.2 D). Unpaired Student’s t-test; *p= 0.0334. 1122 
WT n=4, c-Jun, OE/+ n=3. (D, E) Counts of Fluorogold-labeled sensory (D) and motor (E) 1123 
neurons in WT and c-Jun OE/+ mice following transection with immediate application of 1124 
tracer. The number of back-filled sensory (p=0.1872) and motor (p=0.7153) neurons is 1125 
similar. Unpaired Student’s t-tests, n=3 for each experimental condition. (F) The number of 1126 
back-filled sensory neurons in WT and c-Jun OE/+ mice is similar after transection followed 1127 
by immediate repair. Unpaired Student’s t-test; p= 0.9195. n=3. (G) The number of labeled 1128 
motor neurons in WT and c-Jun OE/+ mice is similar when tracer was applied 5 days after 1129 
sciatic nerve crush. Unpaired Student’s t-test; p=0.312. WT n=5, OE/+ n=4. All numerical 1130 
data represented as means ± SEM, all scale bars: 100µm. 1131 
Figure 6; Source Data 1  1132 
Cell number and nerve size in injured WT and c-Jun OE/+ nerves  1133 
Cell nuclei were counted in whole transverse profiles of the tibial nerve, 5mm from the injury 1134 
site, using the electron microscope. (A) Schwann cell numbers in young and aged WT and c-1135 
Jun OE/+ nerves. (B) Macrophage density and (C) number in young and aged WT and c-Jun 1136 
OE/+ nerves. (D) Fibroblast density and (E) number in young and aged WT and c-Jun OE/+ 1137 
nerves: *p<0.05. (F) Whole transverse profiles of the tibial nerve were measured for the 1138 
nerve area of young and aged WT and c-Jun OE/+ nerves: **p<0.005. For counts in A-F, 1139 
48 
 
n=4 for each condition. (G) Schwann cell numbers in 2 and 10 week cut nerves of WT and c-1140 
Jun OE/+ mice; *p<0.05, **p<0.005, ****p<0.0001. (H) Macrophage density and (I) number in 1141 
2 and 10 week cut nerves of WT and c-Jun OE/+ mice: **p<0.005, ***p<0.001. (J) Fibroblast 1142 
density and (K) number in 2 and 10 week cut nerves of WT and c-Jun OE/+ mice: *p<0.05, 1143 
**p<0.005. (L) Whole transverse profiles of the tibial nerve were measured for the nerve area 1144 
of 2 and 10 week cut nerves of WT and c-Jun OE/+ mice: *p<0.05, ****p<0.0001.  For counts 1145 
in G-L, 2 week WT and c-Jun OE/+ n=7, 10 week WT and c-Jun OE/+ n=5. All number data 1146 
represented as means ± SEM analysed by two-way ANOVA with Tukey’s multiple 1147 
comparison test. 1148 
 1149 
Figure 7: 1150 
 Sonic hedgehog promotes c-Jun activation in Schwann cells in vivo and in vitro 1151 
 (A) Representative Western blot showing c-Jun expression in WT and Shh cKO (cKO) 1152 
nerves 3 and 7 days after cut. Quantitation is shown in the graph where the data are 1153 
normalized to WT 3 days post cut. Two-way ANOVA with Sidak’s test; *p<0.05. n=5 for each 1154 
genotype. (B) Representative Western blot showing c-Jun and phosphorylated c-Jun (p-c-1155 
Jun in WT and Shh cKO distal nerve stumps 7 days post cut. Quantitation is shown in the 1156 
graph where the data are normalized to WT 7 days post cut.  Unpaired Student’s t-test; 1157 
**p=0.0014, n=5 for each genotype. (C) Representative Western blot showing p75NTR 1158 
protein in WT and Shh cKO nerves 7 days post cut. The graph shows quantitation of the 1159 
results.  Data are normalized to WT 7 days post injury. Unpaired Student’s t-test; 1160 
****p=<0.0001. n=5 for each genotype. (D) Representative Western blot showing c-Jun in 1161 
Schwann cell cultures exposed to SAG for 48 hours. (Veh: DMSO vehicle). Quantitation is 1162 
shown in the graph where the data are normalized to vehicle. One-way ANOVA with 1163 
Dunnet’s test; *p<0.05, **p<0.005. n=6. (E) Representative Western blot showing c-Jun in 1164 
Schwann cell cultures exposed to purmorphamine for 48 hours. Quantitation is shown in the 1165 
graph where the data are normalized to vehicle. One-way ANOVA with Dunnet’s test; 1166 
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*p<0.05. n=3. (F) Representative immunofluorescence images showing increased c-Jun 1167 
labeling of Sox10 positive Schwann cell nuclei after 48 hours incubation with SAG compared 1168 
to vehicle (DMSO). Scale bar: 100µm.  1169 
Figure 8: 1170 
 Sonic hedgehog plays a role in c-Jun activation in Schwann cells via autocrine 1171 
signaling 1172 
 (A, B) qPCR showing mRNA expression of (A) Bdnf *p=0.0314 and (B) Gdnf *p=0.0382 in 1173 
Schwann cell cultures incubated for 48 hours with SAG. Data normalized to vehicle.  1174 
Unpaired Student’s t-tests. n=4 for each condition. (C) Differential interference contrast (DIC) 1175 
microscopy showing changes in Schwann cell morphology after 48 hours incubation with 1176 
purmorphamine (DMSO vehicle). Scale bar: 50µm. Graphs depict changes in cell area, 1177 
roundness and length/√area following incubation with purmorphamine, demonstrating 1178 
enhancement of elongated morphology. One-way ANOVAs with Tukey’s multiple 1179 
comparison test ***p<0.001. n= 3, each experiment involving measurement of 100 cells per 1180 
condition. (D) Representative Western blots showing c-Jun and phosphorylated c-Jun in 1181 
cultured Schwann cells after 48 hours incubation with cyclopamine alone (DMSO vehicle). 1182 
The graphs show quantitation of the blots. Data are normalized to vehicle. One-way ANOVA 1183 
with Dunnet’s multiple comparisons test; **p<0.005; ***p<0.001. n=3. All numerical data 1184 
represented as means ± SEM. 1185 
Figure 9; Figure Supplement 1: 1186 
 Bioinformatics analysis of RNA seq. data from young and aged nerves 1187 
(A) Over-representation analysis showing enrichment of c-Jun regulated genes in various 1188 
WT injury paradigms. p= 3.2x10-8 for UI young vs aged; p=1x10x -7 for 3 day cut young vs 1189 
aged; p=2.3x10-13 for the injury response. p-values computed by one-sided Fisher’s exact 1190 
test. (B) GO terms down-regulated and (C) up-regulated in uninjured nerves of aged WT 1191 
mice. (Absolute fold change >2 and FDR<0.05). (D) GO terms down-regulated and (E) up-1192 
regulated in the injury response of aged WT mice. (Absolute fold change >2 and FDR<0.05).  1193 
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(F) When aged c-Jun OE/+ and WT nerves are compared, genes associated with protein 1194 
processing (FDR = 0.00318) and maturation (FDR = 0.0153) are significantly enriched in 1195 
aged c-Jun OE/+ nerves compared to aged WT. (G) Venn diagram showing numbers of 1196 
differentially expressed genes between young and aged 3 day cut WT nerves and aged 3 1197 
day cut OE/+ nerves, compared to their uninjured counterparts. (H) Mean expression of 4 c-1198 
Jun regulated genes with significantly different expression between young and aged WT 1199 
nerves but not between young WT and aged c-Jun OE/+ nerves. (Absolute fold change >2 1200 
and FDR<0.05). 1201 
Figure 9 - Figure Supplement 1 1202 
Bioinformatics analysis of aged and young nerves following injury. (A) Principal component 1203 
analysis (PCA) shows that the key source of variance in our aging analysis is injury status 1204 
with samples clustering together after injury (red) regardless of age or genotype. (B) Gene 1205 
set enrichment analysis (GSEA) of uninjured young and aged WT nerves showed 1206 
enrichment in the down-regulation of c-Jun regulated genes in aged nerves. Normalized 1207 
enrichment score (NES) = -1.85, q-value = 0.0. (C) GSEA analysis comparing injured old 1208 
and young nerves showed a similar enrichment of c-Jun genes in the down-regulation of 1209 
these genes, suggesting a failure of c-Jun regulation in aged nerves. NES= -1.61, q-value = 1210 
0.0. (D) GSEA of young and aged nerves compared to their uninjured controls and then to 1211 
each other to examine the differential expression between the two in response to injury. 1212 
Analysis shows that c-Jun gene up-regulation was highly enriched by injury. NES= 2.01, q-1213 
value = 0.0.  1214 
Figure 10; Figure Supplement 1:  1215 
Bioinformatics analysis of RNA seq. data from acutely and chronically denervated 1216 
nerves  1217 
(A) GO terms down-regulated and (B) up-regulated in WT nerves during chronic 1218 
denervation. (C) When chronically denervated c-Jun OE/+ and WT nerves were compared, 1219 
GO terms associated with Schwann cell differentiation (FDR = 0.00397) and PNS 1220 
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development (FDR = 0.0173) were enriched in c-Jun OE/+ nerves. (D) Venn diagram 1221 
showing numbers of differentially expressed genes between WT nerves following acute (1 1222 
week) and chronic (10 week) denervation and c-Jun OE/+ nerves following chronic 1223 
denervation, compared to their uninjured counterparts. (E) Mean expression of 5 c-Jun 1224 
regulated genes with significantly different expression between acute and chronic WT 1225 
nerves, but not between acute WT and chronic c-Jun OE/+ nerves. (Absolute fold change >2 1226 
and FDR<0.05). 1227 
 1228 
Figure 10 - Figure Supplement 1 1229 
 (A) PCA showing the key sources of variance in our chronic injury analysis are not only 1230 
injury dependent but also time post injury dependent, with samples clustering based on 1231 
length of denervation regardless of genotype. (B) GSEA of WT chronically denervated 1232 
nerves showed that c-Jun genes were some of the most down-regulated genes during 1233 
chronic denervation NES = -2.5, q-value = 0.0.    1234 
 1235 
                                                  SUPPORTING FILES 1236 
Supplementary File 1: The 15 most regulated genes in the tibial nerve of WT mice 1237 
during aging. The data compare (A) uncut nerves, (B) 3 day cut nerves and (C) the injury 1238 
response. In (A) and (B), genes expressed at higher levels in aged mice under the 1239 
conditions indicated are in blue (top), while genes with reduced expression in aged mice are 1240 
in red (bottom). In(C), genes that respond more strongly to injury in aged mice are in blue 1241 
(top), while genes with weaker injury response in aged mice are in red (bottom). 1242 
 1243 
Supplementary File 2: All significantly regulated genes in the tibial nerve of WT mice 1244 
during aging and chronic denervation. (A, B) Genes expressed at higher levels in aged 1245 
mice under the conditions indicated are in blue (top), while genes with reduced expression in 1246 
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aged mice are in red (bottom). (C) Genes that respond more strongly to injury (3 day cut vs 1247 
UI) in aged mice are in blue (top), while genes with weaker injury response are in red 1248 
(bottom). (D) The 303 genes that are significantly expressed in young WT vs UI and aged c-1249 
Jun OE/+ vs UI 3 days after injury. (E) Genes expressed at higher levels after chronic 1250 
denervation are in blue (top), while genes with reduced expression are in red (bottom). (F) 1251 
The 227 genes that are significantly expressed in WT 1 week vs UI and c-Jun OE/+ 10 week 1252 
vs UI. 1253 
 1254 
Supplementary File 3: 138 genes regulated by c-Jun in injured nerves derived from 1255 
Arthur-Farraj et al. (2012). Blue (top) indicates genes expressed at higher levels in cut 1256 
nerves of WT mice compared with nerves of mice with conditional c-Jun inactivation 1257 
selectively in Schwann cells (92 genes), while red (bottom) indicates genes expressed at 1258 
lower levels in cut WT nerves compared to c-Jun mutant nerves (46 genes). 1259 
 1260 
Supplementary File 4: The 15 most regulated genes in the tibial nerve during chronic 1261 
denervation. Genes expressed at higher levels after chronic denervation are in blue (top), 1262 
while genes with reduced expression are in red (bottom). 1263 
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